Lazard Asset Management LLC Tekla Life Sciences Investors Transaction History

Lazard Asset Management LLC

$68.3 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Nov 14, 2023	SELL	$12.38 - $13.69 $16,601 - $18,358	-1,341 Reduced 0.72%	183,991 $2.29 Million
Q3 2021 Nov 15, 2021	SELL	$20.27 - $22.67 $387,765 - $433,677	-19,130 Reduced 9.36%	185,332 $3.85 Million
Q3 2020 Nov 13, 2020	BUY	$16.71 - $19.06 $198,715 - $226,661	11,892 Added 6.18%	204,462 $3.59 Million
Q2 2020 Aug 13, 2020	BUY	$14.22 - $18.38 $2.11 Million - $2.73 Million	148,525 Added 337.21%	192,570 $3.46 Million
Q1 2020 May 14, 2020	BUY	$12.22 - $17.99 $538,229 - $792,369	44,045 New	44,045 $659,000

Others Institutions Holding HQL

# of Institutions

76

Shares Held

9.23M

Call Options Held

0

Put Options Held

0

Saba Capital Management, L.P. New York, NY

3.43M
Shares

$47.2 Million
1.1% of portfolio
Penserra Capital Management LLC Orinda, CA

776K
Shares

$10.7 Million
0.25% of portfolio
Morgan Stanley New York, NY

490K
Shares

$6.74 Million
0.0% of portfolio
Karpus Management, Inc. Pittsford, NY

469K
Shares

$6.45 Million
0.23% of portfolio
Sit Investment Associates Inc Minneapolis, MN

417K
Shares

$5.74 Million
0.14% of portfolio

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.